| Date Filed | Type | Description |
| 07/06/2023 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Paid exercise price by delivering 12,946 shares
@ $3.08, valued at
$39.9k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/13/2022 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on Talaris Therapeutics, Inc.|
Txns:
| Granted 1,000 shares
@ $13, valued at
$13k
Granted 200,000 options to buy
@ $9.1, valued at
$1.8M
|
|
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/01/2020 |
3
| Fenton Mary Kay (Director) has filed a Form 3 on Oncorus, Inc. |
| 02/13/2018 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 250,000 options to buy
@ $2.9, valued at
$725k
|
|
| 01/19/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/22/2016 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 118,000 options to buy
@ $7.61, valued at
$898k
|
|
| 12/30/2015 |
4
| Fenton Mary Kay (CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 43,500 shares
@ $10.08, valued at
$438.5k
Exercised 43,500 options to buy
@ $1.05, valued at
$45.7k
|
|
| 01/23/2015 |
4
| Fenton Mary Kay (EVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 13,125 shares
@ $16, valued at
$210k
Exercised 13,125 options to buy
@ $4, valued at
$52.5k
|
|
| 12/04/2014 |
4
| Fenton Mary Kay (EVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 110,000 options to buy
@ $13.24, valued at
$1.5M
|
|
| 03/06/2014 |
4
| Fenton Mary Kay (EVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 30,000 options to buy
@ $3.66, valued at
$109.8k
|
|
| 12/19/2013 |
4
| Fenton Mary Kay (SVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 250,000 options to buy
@ $3.02, valued at
$755k
|
|
| 12/20/2012 |
4
| Fenton Mary Kay (SVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 145,000 options to buy
@ $8.64, valued at
$1.3M
|
|
| 01/11/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/14/2011 |
4
| Fenton Mary Kay (SVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Granted 75,000 options to buy
@ $7.59, valued at
$569.3k
|
|
| 04/06/2011 |
4
| Fenton Mary Kay (SVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 4,111 shares
@ $7.5, valued at
$30.8k
Sold 139 shares
@ $7.5, valued at
$1k
|
|
| 04/01/2011 |
4
| Fenton Mary Kay (SVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 4,000 shares
@ $7.5, valued at
$30k
|
|
| 01/18/2011 |
4
| Fenton Mary Kay (SVP and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC|
Txns:
| Sold 8,750 shares
@ $5, valued at
$43.8k
|
|
| 12/20/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/22/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/17/2008 |
4
| Fenton Mary Kay (Vice President and CFO) has filed a Form 4 on ACHILLION PHARMACEUTICALS INC |